AI for Optometry Practices: What Actually Works in 2026

The short version: in optometry, the AI that pays for itself fills the exam schedule with recalls, lifts the frame capture rate, and keeps VSP claims clean. Everything else is garnish. Two hundred exams a month mean nothing if half the patients buy their glasses online — the exam is the loss leader, the optical is the business. Also see Optometry, Payments for Optometry, and Tech for Optometry.

The one number that matters: frame capture rate

200 exams a month. Frame capture rate: 50%. Average glasses sale: $400.

200 x 50% x $400 = $40,000 a month in optical revenue. Lift capture from 50% to 60% — ten points — and that's $8,000 more a month, $96,000 a year, from patients already sitting in your exam chair. No new marketing. No new patients. Just keeping the sale you already earned.

The second number: recall response. The annual exam reminder goes out, and what — 30%? 40%? — actually book. Every exam that doesn't happen is a $150 visit plus a $400 glasses opportunity that evaporates. A recall sequence that lifts response 10 points on a 2,000-patient recall list is 200 more exams a year — $30,000 in exams and, at 50% capture, $40,000 in optical. Pull both numbers this week: frame capture rate and recall response rate. The AI business case is sitting in those two reports.

The one that pays for itself: recall automation that actually books

Real prices, checked October 2026:

• 4PatientCare — the optometry-native recall company: automated calls, texts, and emails for annual exams, quote-based (third-party estimates ~$200–$400/mo). It's done nothing but recalls for decades — boring, effective.
• Weave — phone plus AI call handling, plans from ~$399/mo per location. The all-rounder: recalls, reviews, payments, and the phone in one.
• Solutionreach — quote-based (third-party estimates ~$299–$499/mo), with vision-plan-aware messaging.
• RevolutionEHR RevConnect — bundled patient messaging inside RevolutionEHR; convenient if you're on RevEHR, but evaluate the recall depth against a dedicated platform.

The recall sequence that works: text at 11 months (“time for your annual eye exam”), call or text at 12, then monthly with a different angle each time — the vision-benefit angle (“use it before it resets”), the health angle (“your last retinal photos were 14 months ago”), the convenience angle (“Saturday appointments available”). The same text three times is nagging; three different reasons is marketing.

Spanish, as always: in most markets a large share of your patient base prefers Spanish, and the annual recall text in English is the exam that goes to the online guys. Test in Spanish before you sign. Get the signed BAA before go-live — exam history is PHI. Skip it if your recall response is already above 60% — you're the exception; spend it on frame capture instead.

How to use AI voice to get paid: the four-minute optical checkout

The workflow that kills “patients who exam here, buy online”:

• Minute 0 — speak the sale. Optician at the frame board: “Progressives, premium AR, the Nguyen family — two pairs. $850 total, VSP covers $400, patient portion $450. Second pair 30% off applied. Card on file for the balance.”
• Minute 1 — the AI builds the invoice. Transcribes, structures the frame and lens options, attaches the VSP authorization and the prescription. You approve on your phone.
• Minute 2 — the patient gets a text. Invoice plus a secure payment link for the $450, before they've left the optical.
• Minutes 3–4 — the money lands. Patient taps, pays by card or FSA. The VSP claim files automatically from the same data — no retyping the sale into the vision-plan portal.

ClaroPro pairs bilingual voice-to-invoice with payments — it must understand “progressives,” “premium AR,” and “VSP authorization” without spelling lessons. The optician explained the options in Spanish and the patient chose English — the invoice goes out in English.

Two disciplines make or break it. First, present the second pair at every dispense: the AI invoice defaults to showing the two-pair price with the discount applied, because the second pair is pure margin and nobody buys it at home later. Second, the VSP eligibility check happens before the exam, not after — the invoice should never surprise anyone with a denied benefit. What kills it: a voice tool with no payments is a dictation app, and optical sales that wait for “we'll think about it” are optical sales that happen online. Rule: the glasses are sold and paid at the frame board — the exam room is for the prescription, the optical is for the revenue.

Frame capture: the AI-assisted optical

The optical is where AI earns its keep beyond reminders:

• Pickup reminders that sell the second pair. “Your glasses are ready” text plus the optician's note: “we held the sunglasses in your prescription — want to see them at pickup?” The pickup visit is the highest-converting sales moment in the practice; the text makes sure it happens.
• Virtual try-on as a pre-visit tool. Send the try-on link with the recall text — patients arrive with three favorites picked, and the frame board conversation starts at “which one” instead of “overwhelmed.” It doesn't replace the optician; it pre-sells for her.
• Inventory nudges. Frames sitting 180+ days get flagged automatically — mark them down, bundle them as the second pair, move them. Dead inventory is a silent margin killer; the AI just points at it.

The honest caveat: virtual try-on converts browsers, not buyers — the sale still closes at the frame board with a human. Don't buy AI try-on expecting it to replace the optician; buy it to make her 20% more productive. Skip it if your capture rate is already above 70% — you're optimized; spend it on recalls instead.

Clinical AI: diabetic retinopathy screening that pays

Optometry has one genuinely FDA-cleared clinical AI worth knowing: LumineticsCore (formerly IDx-DR) — autonomous AI for diabetic retinopathy detection, FDA-cleared via De Novo. The camera takes the retinal images, the AI grades them on the spot, no specialist overread required for the screening decision.

Why it matters for the business, not just the medicine: diabetic patients need annual dilated exams they're not getting, and the AI screening turns your practice into the place that catches it. It bills as a screening service, differentiates the practice from the online exam crowd, and — critically — it's a medical service in an optical business, which means it doesn't compete with Warby Parker on anything.

The honest caveat: it's a screening tool, not a diagnosis — positives still need the dilated exam and referral. And the camera plus AI is a capital purchase, not a subscription; run the per-patient economics before the demo dazzles you. Skip it if your practice is 95% routine vision with no medical panel — the volume isn't there.

Compliance: HIPAA, CA AB 3030, TX SB 1188

Three rules, plain English:

• HIPAA: signed BAA before go-live for the phone AI, recall platform, reminders, and review tool. Exam history and prescriptions are PHI — all of it.
• California AB 3030 (in effect since January 2025): generative AI communicating clinical info to patients — AI-drafted exam summaries, screening results messages — must disclose AI use and how to reach a human. Build it into the template.
• Texas SB 1188 (effective January 2026): AI must identify itself and can't be deployed to deceive. The greeting covers it.

Optometry-specific trap: VSP and vision-plan marketing rules. Your recall texts can't promise vision-plan coverage you haven't verified — “your VSP benefits renew soon” is fine; “you're covered for $400 in frames” without an eligibility check is a complaint waiting to happen. Verify eligibility before the exam, market the verified benefit after. And the review rule: AI drafts, you approve, and no public reply ever confirms someone is your patient.

What to ignore

• Chatbots that can't book an exam — if it doesn't write to your schedule, it's a toy.
• AI “eye disease detection” from a phone selfie — not LumineticsCore, not FDA-cleared, not your license's friend.
• Fully automated review posting — one hallucinated reply and you're writing responses yourself anyway.
• “AI marketing” as a separate product — Google and Meta already optimize the auction; you're buying a dashboard.
• AI-generated “what your vision could look like” simulations — fun, but patients remember the simulation, not the disclaimer.
• Vanity AI: sentiment dashboards with no action attached — if it doesn't change what your optician does Tuesday morning, it's wallpaper.

FAQ

What's the single highest-ROI AI move in optometry? Annual recall sequences. The exam you don't remind is the exam the online guys get — and every recalled exam is a $400 optical opportunity.

How do I lift frame capture rate? Present the second pair at every dispense, send the try-on link with the recall text, and invoice at the frame board before “we'll think about it” walks out the door.

4PatientCare vs. Weave for recalls? 4PatientCare if recalls are the whole job and you want the optometry-native specialist. Weave if you want recalls plus the phone, reviews, and payments in one contract.

Do I need a BAA for the recall texts? Yes — exam history is PHI. Any vendor in this space should hand you one.

Is the diabetic retinopathy AI worth it? If you have a medical panel and diabetic volume — it's a differentiator the online exam can't copy. If you're 95% routine vision, the capital purchase doesn't pencil out.

Monthly cost for the stack? $300–$700/mo for recall automation plus AI phone at typical volumes. Ten points of capture rate cover it hundreds of times over.

Rollout order, cheapest win first: 1) Annual recall sequences this week — the exam you don't remind is the exam Warby Parker gets. 2) Frame-pickup and second-pair follow-ups. 3) AI phone answering for after-hours bookings. 4) Eligibility automation before the exam, not after. Pull your recall response rate and your frame capture rate first — those two numbers are the business case. Then read Payments for Optometry: the optical counter is where the margin lives, and the processor takes its cut there.